Scilex Holding Co Share Price Today: Live Updates & Key Insights

Scilex Holding Co share price today is $7.52, up -3.59%. The stock opened at $7.61 against the previous close of $7.8, with an intraday high of $7.75 and low of $7.35.

Scilex Holding Co Share Price Chart

Scilex Holding Co

us-stock
To Invest in {{usstockname}}
us-stock

Scilex Holding Co Share Price Performance

$7.52 -0.0359(-3.59%) SCLX at 23 Mar 2026 03:09 PM Drug Manufacturers - General
Lowest Today 7.35
Highest Today 7.75
Today’s Open 7.61
Prev. Close 7.8
52 Week High 34.27
52 Week Low 3.60
Day’s Range: Low 7.35 High 7.75
52-Week Range: Low 3.60 High 34.27
1 day return -
1 Week return -12.29
1 month return -6.13
3 month return -48.31
6 month return -75.47
1 year return +2539.13
3 year return -4.04
5 year return -25.75
10 year return -

Scilex Holding Co Institutional Holdings

Armistice Capital, LLC 6.78

Vanguard Group Inc 4.19

Vanguard Total Stock Mkt Idx Inv 2.51

BlackRock Inc 1.40

Vanguard Institutional Extnd Mkt Idx Tr 1.09

Renaissance Technologies Corp 0.55

State Street Corp 0.48

683 Capital Management LLC 0.39

UBS Group AG 0.36

Morgan Stanley - Brokerage Accounts 0.33

Blackrock Extended Mkt Fund CF 0.29

Bank of America Corp 0.25

Extended Equity Market Fund K 0.24

iShares Micro-Cap ETF 0.23

Northern Trust Corp 0.22

iShares Core S&P Total US Stock Mkt ETF 0.21

Omers Administration Corp 0.17

Donald L. Hagan, LLC 0.17

Qube Research & Technologies 0.16

Quantinno Capital Management LP 0.16

Belfund SICAV Belinvest Equity A USD Acc 0.11

NT Ext Equity Mkt Idx Fd - NL 0.11

Northern Trust Extended Eq Market Idx 0.10

NT Ext Equity Mkt Idx Fd - L 0.10

T. Rowe Price Extended Equity Market Idx 0.10

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.08

Vanguard Instl Ttl Stck Mkt Idx Tr 0.07

Barclays PLC 0.06

Vanguard Instl Ttl Stk Mkt Idx InstlPls 0.05

T. Rowe Price U.S. Equities Tr 0.04

Vanguard U.S. Eq Idx £ Acc 0.04

Tower Research Capital LLC 0.04

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.04

State St US Extended Mkt Indx NL Cl C 0.03

Extended Equity Market Fund M 0.03

Creative Financial Designs Inc 0.03

SWC (CH) IPF I IEF SmCp Wld ex CH NA CHF 0.02

Advisor Group Holdings, Inc. 0.02

MetLife Investment Management, LLC 0.02

JONES FINANCIAL COMPANIES LLLP 0.01

Scilex Holding Co Market Status

Strong Buy: 1

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Scilex Holding Co Fundamentals

Market Cap 52.89 M

PB Ratio 28.8516

PE Ratio 0.0

Enterprise Value 105.85 M

Total Assets 92.95 M

Volume 28984

Scilex Holding Co Company Financials

Annual Revenue FY23:45200000 45.2M, FY22:38034000 38.0M, FY21:31317000 31.3M, FY20:23560000 23.6M, FY19:21033000 21.0M

Annual Profit FY23:29527000 29.5M, FY22:27237000 27.2M, FY21:27683000 27.7M, FY20:21411000 21.4M, FY19:15231000 15.2M

Annual Net worth FY23:-110815000 -110.8M, FY22:-23364000 -23.4M, FY21:-88424000 -88.4M, FY20:-47519000 -47.5M, FY19:-178594000 -178.6M

Quarterly Revenue Q3/2025:10560000 10.6M, Q2/2025:9896000 9.9M, Q1/2025:5004000 5.0M, Q4/2024:14436000 14.4M, Q3/2024:14436000 14.4M

Quarterly Profit Q3/2025:7231000 7.2M, Q2/2025:6624000 6.6M, Q1/2025:3620000 3.6M, Q4/2024:10668000 10.7M, Q3/2024:10668000 10.7M

Quarterly Net worth Q3/2025:-257234000 -257.2M, Q2/2025:-86061000 -86.1M, Q1/2025:-26080000 -26.1M, Q4/2024:-4388000 -4.4M, Q3/2024:-4388000 -4.4M

About Scilex Holding Co & investment objective

Company Information Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company also develops three product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel - SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4%, a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules), a novel low-dose delayed-release naltrexone hydrochloride, which has completed phase 1 trials for the treatment of fibromyalgia. It has an agreement with Oishi and Itochu to develop lidocaine tape products, including ZTlido and SP-103; and Lifecore Biomedical, LLC for clinical trial material manufacturing and development services for SEMDEXA. Scilex Holding Company is based in Palo Alto, California.

Organisation Drug Manufacturers - General

Employees 30

Industry Drug Manufacturers - General

CEO Dr. Henry H. Ji Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Scilex Holding Co FAQs

What is the share price of Scilex Holding Co today?

The current share price of Scilex Holding Co is $7.52.

Can I buy Scilex Holding Co shares in India?

Yes, Indian investors can buy Scilex Holding Co shares by opening an international trading and demat account with Motilal Oswal.

How to buy Scilex Holding Co shares in India?

You can easily invest in Scilex Holding Co shares from India by:

Can I buy fractional shares of Scilex Holding Co?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Scilex Holding Co?

Scilex Holding Co has a market cap of $52.89 M.

In which sector does Scilex Holding Co belong?

Scilex Holding Co operates in the Drug Manufacturers - General sector.

What documents are required to invest in Scilex Holding Co stocks?

To invest, you typically need:

What is the PE and PB ratio of Scilex Holding Co?

The PE ratio of Scilex Holding Co is N/A and the PB ratio is 28.85.